Статті для всіх - Vittorio PengoДокладніше
Недоступно ніде: 7
Antiphosphatidylserine/prothrombin antibodies: an update on their association with clinical manifestations of antiphospholipid syndrome
M Radin, SG Foddai, I Cecchi, E Rubini, K Schreiber, D Roccatello, ...
Thrombosis and haemostasis 120 (04), 592-598, 2020
Мандати: British Heart Foundation, Government of Italy
Platelet activation by antiphospholipid antibodies depends on epitope specificity and is prevented by mTOR inhibitors
A Hollerbach, N Müller-Calleja, S Ritter, F Häuser, A Canisius, C Orning, ...
Thrombosis and haemostasis 119 (07), 1147-1153, 2019
Мандати: Federal Ministry of Education and Research, Germany
Antiphospholipid syndrome in chronic thromboembolic pulmonary hypertension: a well-defined subgroup of patients
X Jiang, Y Du, CY Cheng, G Denas, YP Zhou, T Wu, YX Zhang, ZY Han, ...
Thrombosis and haemostasis 119 (09), 1403-1408, 2019
Мандати: National Natural Science Foundation of China
Prevalence of antiphospholipid (aPL) antibodies among patients with chronic thromboembolic pulmonary hypertension: a systematic review and meta-analysis
CY Cheng, YX Zhang, G Denas, Y Du, ZC Jing, V Pengo
Internal and Emergency Medicine 14, 521-527, 2019
Мандати: National Natural Science Foundation of China
Population differences in S-warfarin pharmacokinetics among African Americans, Asians and whites: their influence on pharmacogenetic dosing algorithms
K Kubo, M Ohara, M Tachikawa, LH Cavallari, MTM Lee, MS Wen, ...
The Pharmacogenomics Journal 17 (6), 494-500, 2017
Мандати: US National Institutes of Health, American Heart Association
Immunosuppression use in primary antiphospholipid antibody-positive patients: Descriptive analysis of the AntiPhospholipid Syndrome Alliance for Clinical Trials and …
ZB Erton, R K Leaf, D de Andrade, AE Clarke, MG Tektonidou, V Pengo, ...
Lupus 31 (14), 1770-1776, 2022
Мандати: US National Institutes of Health
Correlations between the enantio-and regio-selective metabolisms of warfarin
H Takahashi, M Ohara, S Shibata, MTM Lee, LH Cavallari, EA Nutescu, ...
Pharmacogenomics 18 (2), 133-142, 2017
Мандати: American Heart Association, Government of Italy
Доступно в інших місцях: 31
EULAR recommendations for the management of antiphospholipid syndrome in adults
MG Tektonidou, L Andreoli, M Limper, Z Amoura, R Cervera, ...
Annals of the rheumatic diseases 78 (10), 1296-1304, 2019
Мандати: US National Institutes of Health
The adjusted global antiphospholipid syndrome score (aGAPSS) and the risk of recurrent thrombosis: results from the APS ACTION cohort
M Radin, S Sciascia, D Erkan, V Pengo, MG Tektonidou, A Ugarte, ...
Seminars in arthritis and rheumatism 49 (3), 464-468, 2019
Мандати: US National Institutes of Health
Direct oral anticoagulants vs vitamin K antagonists in patients with antiphospholipid syndromes: meta-analysis of randomized trials
CD Khairani, A Bejjani, G Piazza, D Jimenez, M Monreal, S Chatterjee, ...
Journal of the American College of Cardiology 81 (1), 16-30, 2023
Мандати: US National Institutes of Health, American Heart Association
Impact of the CYP4F2 p.V433M Polymorphism on Coumarin Dose Requirement: Systematic Review and Meta‐Analysis
E Danese, M Montagnana, JA Johnson, AE Rettie, CF Zambon, SA Lubitz, ...
Clinical Pharmacology & Therapeutics 92 (6), 746-756, 2012
Мандати: US National Institutes of Health
Development of a new international antiphospholipid syndrome classification criteria phase I/II report: generation and reduction of candidate criteria
M Barbhaiya, S Zuily, Y Ahmadzadeh, MC Amigo, T Avcin, ...
Arthritis care & research 73 (10), 1490-1501, 2021
Мандати: US National Institutes of Health, British Heart Foundation
Global anticoagulant registry in the field–venous thromboembolism (GARFIELD-VTE)
JI Weitz, S Haas, W Ageno, P Angchaisuksiri, H Bounameaux, JD Nielsen, ...
Thrombosis and haemostasis 116 (12), 1172-1179, 2016
Мандати: US National Institutes of Health, Natural Sciences and Engineering Research …
Characteristics of patients with antiphospholipid antibody positivity in the APS ACTION international clinical database and repository
E Sevim, D Zisa, D Andrade, S Sciascia, V Pengo, MG Tektonidou, ...
Arthritis care & research 74 (2), 324-335, 2022
Мандати: US National Institutes of Health, Natural Sciences and Engineering Research …
The impact of systemic lupus erythematosus on the clinical phenotype of antiphospholipid antibody–positive patients: results from the antiphospholipid syndrome alliance for …
O Unlu, D Erkan, M Barbhaiya, D Andrade, I Nascimento, R Rosa, ...
Arthritis care & research 71 (1), 134-141, 2019
Мандати: US National Institutes of Health
Factors associated with first thrombosis in patients presenting with obstetric antiphospholipid syndrome (APS) in the APS Alliance for Clinical Trials and International …
GR de Jesús, S Sciascia, D Andrade, M Barbhaiya, M Tektonidou, ...
BJOG: An International Journal of Obstetrics & Gynaecology 126 (5), 656-661, 2019
Мандати: US National Institutes of Health
High intensity anticoagulation in the prevention of the recurrence of arterial thrombosis in antiphospholipid syndrome:‘PROS’and ‘CONS’
V Pengo, G Ruiz-Irastorza, G Denas, L Andreoli, M Khamashta, A Tincani
Autoimmunity reviews 11 (8), 577-580, 2012
Мандати: Government of Spain
Cluster analysis for the identification of clinical phenotypes among antiphospholipid antibody-positive patients from the APS ACTION Registry
S Zuily, I Clerc-Urmès, C Bauman, D Andrade, S Sciascia, V Pengo, ...
Lupus 29 (11), 1353-1363, 2020
Мандати: US National Institutes of Health, British Heart Foundation
Effect of CYP4F2, VKORC1, and CYP2C9 in Influencing Coumarin Dose: A Single‐Patient Data Meta‐Analysis in More Than 15,000 Individuals
E Danese, S Raimondi, M Montagnana, A Tagetti, T Langaee, P Borgiani, ...
Clinical Pharmacology & Therapeutics 105 (6), 1477-1491, 2019
Мандати: US National Institutes of Health, British Heart Foundation, UK Medical …
Cardiovascular risk factors are major determinants of thrombotic risk in patients with the lupus anticoagulant
F Posch, J Gebhart, JH Rand, S Koder, P Quehenberger, V Pengo, C Ay, ...
BMC medicine 15, 1-13, 2017
Мандати: Austrian Science Fund
Дані про публікацію й грошову підтримку визначаються автоматично комп'ютерною програмою